Delaloge S, Piccart M, Rutgers E, Litiere S, et al. Standard Anthracycline Based Versus Docetaxel-Capecitabine in Early High Clinical and/or Genomic Risk Breast Cancer in the EORTC 10041/BIG 3-04 MINDACT Phase III Trial. J Clin Oncol 2020 Feb 21:JCO1901371. doi: 10.1200/JCO.19.01371.
PMID: 32083990